Amoxapine as an atypical antipsychotic: a comparative study vs risperidone (Q34426638)

2 August 2017

Amoxapine as an atypical antipsychotic: a comparative study vs risperidone (English)

1 reference

2 August 2017

1 reference

8

1 reference

Camilo de la Fuente-Sandoval

2 August 2017

7

Humberto Nicolini

0 references

4

object named as

Camilo de la Fuente-Sandoval

0 references

Rogelio Apiquian

object named as

Rogelio Apiquian

1

0 references

author name string

Ana Fresan

2

1 reference

2 August 2017

Rosa-Elena Ulloa

3

1 reference

2 August 2017

Miguel Herrera-Estrella

5

1 reference

2 August 2017

Alejandra Vazquez

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

2 August 2017

Neuropsychopharmacology

1 reference

2 August 2017

30

1 reference

2 August 2017

12

1 reference

2 August 2017

2236-2244

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300796

2 August 2017

0 references

cites work

Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

Amoxapine shows atypical antipsychotic effects in patients with schizophrenia: results from a prospective open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

A rating scale for drug-induced akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

Second generation antidepressants: a comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

Treatment of schizophrenia in low-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

Amoxapine in schizophrenia: a negative double-blind controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

Prescription of antipsychotic drugs by office-based physicians in the United States, 1989-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

Is amoxapine an atypical antipsychotic? Positron-emission tomography investigation of its dopamine2 and serotonin2 occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

Mechanisms of action of atypical antipsychotic drugs: a critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

Amoxapine - An Antidepressant With Some Neuroleptic Properties?: A Review of Its Chemistry, Animal Pharmacology and Toxicology, Human Pharmacology, and Clinical Efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

Determining the optimal dose of haloperidol in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

Antipsychoticlike effects of amoxapine, without catalepsy, using the prepulse inhibition of the acoustic startle reflex test in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

7 January 2021

Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

7 January 2021

Efficacy of amoxapine in psychotic depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

7 January 2021

Amoxapine elevates serum prolactin in depressed men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

7 January 2021

Amoxapine (Asendin, Lederle Laboratories).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

7 January 2021

Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

7 January 2021

Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300796

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300796

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference